Clinical trial
Freeze-dried Live Attenuated Measles and Rubella Combined Vaccine "Takeda" Specified Drug-use Survey of Vaccinees After the Second Vaccination
NCT02158364 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Freeze-dried Live Attenuated Measles and Rubella Combined Vaccine "Takeda" Specified Drug-use Survey of Vaccinees After the Second Vaccination
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 28, 2007
- Completion date
- February 20, 2011
- Enrollment
- 3,331 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
measles/rubella